ADC Therapeutics Valuation
| ADCT Stock | USD 4.78 0.19 3.82% |
At this time, the firm appears to be overvalued. ADC Therapeutics owns a latest Real Value of $3.85 per share. The recent price of the firm is $4.78. Our model approximates the value of ADC Therapeutics from examining the firm fundamentals such as shares owned by insiders of 29.00 %, and Return On Asset of -0.25 as well as evaluating its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued equities and selling overvalued equities since, at some future date, asset prices and their ongoing real values will grow together. Key fundamental drivers impacting ADC Therapeutics' valuation include:
Price Book 2.5787 | Enterprise Value 535.6 M | Enterprise Value Ebitda (1.43) | Price Sales 5.2087 | Enterprise Value Revenue 2.9915 |
Overvalued
Today
Please note that ADC Therapeutics' price fluctuation is very risky at this time. Calculation of the real value of ADC Therapeutics is based on 3 months time horizon. Increasing ADC Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for ADC Therapeutics SA is useful when determining the fair value of the ADC stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of ADC Therapeutics. Since ADC Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ADC Stock. However, ADC Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.78 | Real 3.85 | Target 8.6 | Hype 4.97 | Naive 4.59 |
The real value of ADC Stock, also known as its intrinsic value, is the underlying worth of ADC Therapeutics Company, which is reflected in its stock price. It is based on ADC Therapeutics' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of ADC Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ADC Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ADC Therapeutics SA helps investors to forecast how ADC stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ADC Therapeutics more accurately as focusing exclusively on ADC Therapeutics' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use ADC Therapeutics' intrinsic value based on its ongoing forecasts of ADC Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against ADC Therapeutics' closest peers. When choosing an evaluation method for ADC Therapeutics, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
ADC Therapeutics Investments |
|
ADC Valuation Trend
Knowing ADC Therapeutics' actual value is paramount for traders to make sound investment determinations. ADC Therapeutics' real value is not only important for the investor to make better decisions but also for a more accurate overall view of ADC Therapeutics' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both ADC Therapeutics' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
ADC Market Cap
ADC Therapeutics SA is number one stock in market capitalization category among related companies. Market capitalization of Information Technology industry is presently estimated at about 2.82 Billion. ADC Therapeutics retains roughly 410.17 Million in market capitalization claiming about 15% of equities under Information Technology industry.ADC Therapeutics Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining ADC Therapeutics's current stock value. Our valuation model uses many indicators to compare ADC Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ADC Therapeutics competition to find correlations between indicators driving ADC Therapeutics's intrinsic value. More Info.ADC Therapeutics SA is number one stock in price to earning category among related companies. It is number one stock in price to book category among related companies fabricating about 0.13 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for ADC Therapeutics SA is roughly 7.68 . Price To Book Ratio is likely to gain to -0.87 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value ADC Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ADC Therapeutics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ADC Therapeutics' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ADC Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ADC Therapeutics and how it compares across the competition.
About ADC Therapeutics Valuation
The stock valuation mechanism determines the current worth of ADC Therapeutics SA on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of ADC Therapeutics SA. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of ADC Therapeutics based exclusively on its fundamental and basic technical indicators. By analyzing ADC Therapeutics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of ADC Therapeutics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of ADC Therapeutics. We calculate exposure to ADC Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ADC Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 77.1 M | 80.9 M | |
| Pretax Profit Margin | (2.81) | (2.95) | |
| Operating Profit Margin | (2.39) | (2.51) | |
| Net Loss | (3.45) | (3.62) | |
| Gross Profit Margin | 0.96 | 1.01 |
8 Steps to conduct ADC Therapeutics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ADC Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ADC Therapeutics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain ADC Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ADC Therapeutics' revenue streams: Identify ADC Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ADC Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish ADC Therapeutics' growth potential: Evaluate ADC Therapeutics' management, business model, and growth potential.
- Determine ADC Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ADC Therapeutics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
ADC Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as ADC Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 81.7 M |
ADC Therapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of ADC Therapeutics SA and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value ADC we look at many different elements of the entity such as ADC's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. ADC Therapeutics' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final ADC Therapeutics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as ADC Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use ADC Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes ADC Therapeutics' worth.When determining whether ADC Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ADC Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Adc Therapeutics Sa Stock. Highlighted below are key reports to facilitate an investment decision about Adc Therapeutics Sa Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ADC Therapeutics SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the ADC Therapeutics information on this page should be used as a complementary analysis to other ADC Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for ADC Stock analysis
When running ADC Therapeutics' price analysis, check to measure ADC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADC Therapeutics is operating at the current time. Most of ADC Therapeutics' value examination focuses on studying past and present price action to predict the probability of ADC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADC Therapeutics' price. Additionally, you may evaluate how the addition of ADC Therapeutics to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is ADC Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADC Therapeutics. If investors know ADC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ADC Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.94) | Revenue Per Share 0.851 | Quarterly Revenue Growth (0.76) | Return On Assets (0.25) | Return On Equity (7.06) |
The market value of ADC Therapeutics is measured differently than its book value, which is the value of ADC that is recorded on the company's balance sheet. Investors also form their own opinion of ADC Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is ADC Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ADC Therapeutics' market value can be influenced by many factors that don't directly affect ADC Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ADC Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ADC Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ADC Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.